We tackle the unmet needs of patients
Innovation in Biotech and Life Sciences are bringing about immense opportunities for improved and extended lives. 20 years ago, with purpose and thoughtfulness, we embarked on advancing drug discovery and development to solve critical healthcare issues.
Science meets entrepreneurialism
Many of our investments begin with ideas that turn novel science and IP into breakthrough applications, or proprietary IP for fueling unique solutions. We invest at all phases of a company’s lifecycle starting with incubating novel ideas. Our world-class team of business and science experts advance entrepreneurial passion by leveraging our platforms and expertise. Our global eco-community, mentors and supports CEOs in complex business initiatives as well as day-to-day operations, enabling numerous successful outcomes.
Revolutionizing biopharma
Preclinical cancer drug discovery, small molecule, large molecule and cell therapy are key focuses. Portfolio companies are breaking new ground in these areas. BioAtla, our Drug Discovery services platform, is revolutionizing cancer therapies with leading-edge CAB technology, achieving greater efficacy and cost efficiencies. BioDuro-Sundia, the third largest CRDMO and one of our earliest biopharma ventures, continues to prove itself as a global leader in pharmaceutical manufacturing. CDMO BioCina has been recognized as one of the fastest growing companies in biopharma in Australia due to their unparalleled quality and customer service.
